Viewing Study NCT02603705


Ignite Creation Date: 2025-12-25 @ 3:23 AM
Ignite Modification Date: 2026-05-24 @ 7:16 PM
Study NCT ID: NCT02603705
Status: COMPLETED
Last Update Posted: 2018-03-05
First Post: 2015-11-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
Sponsor: Egalet Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Moderate-to-severe Chronic Noncancer Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chronic pain View
None opioid View
None oxycodone View
None non cancer pain View
None moderate to severe View